Abiopharma

LTM lancia BlueVerse™ su Databricks per accelerare la monetizzazione dellAI

GRI Bio Secures FDA Orphan Drug Designation for GRI-0621 (Tazarotene) in Idiopathic Pulmonary Fibrosis

LTM lance BlueVerse™ sur Databricks pour accélérer la monétisation de lIA

LTM führt BlueVerse™ for Databricks ein zwecks Beschleunigung der KI-Monetarisierung

COSCIENS Biopharma Inc. Announces Results of Shareholder Meeting and Appointment of Full-Time CEO

Schrödinger, Inc. - Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

LIXTE Biotechnology Provides Update on NOMAD Acquisition; Transaction Expected to Close On or About July 1, 2026

MAIA Biotechnology Opens Enrollment for Phase 2 Expansion Trial of Novel Telomere-Targeting Agent at Winship Cancer Institute of Emory University

SR BANCORP, INC. ANNOUNCES 20% INCREASE IN QUARTERLY DIVIDEND

Quoin Pharmaceuticals Completes Establishment of Japanese Subsidiary to Advance Commercial Readiness for QRX003